Physician profile
John M Harris
NPI 1083619886
$5,131.95
in general payments reported to CMS, 2019-2025
18 companies · $83.43 in 2025
The $83.43 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,228 · 2020: $1,472 · 2021: $914 · 2022: $224 · 2023: $196 · 2024: $15.54 · 2025: $83.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,930.36 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $1,015.81 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $489.82 | 2019-2024 | Gore Synecor Biomaterial |
| Karl Storz Endoscopy-America | $136.94 | 2019-2021 | |
| Ethicon US, LLC | $134.53 | 2019-2023 | Mega Soft |
| Allergan, INC. | $93.67 | 2019 | |
| Pfizer INC. | $75.94 | 2019 | |
| Tela Bio, INC. | $56.08 | 2020-2022 | |
| Csl Behring | $35.30 | 2019 | |
| Medtronic, INC. | $25.25 | 2022 | |
| Boston Scientific Corporation | $24.67 | 2021 | |
| Evoke Pharma, INC. | $20.61 | 2025 | |
| Conmed Corporation | $18.26 | 2023 | Airseal |
| Integra Lifesciences Corporation | $18.00 | 2022 | |
| Olympus America INC. | $15.39 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.28 | 2019 | |
| Covidien LP | $13.27 | 2019 | |
| Medtronic Vascular, INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.